- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Laboratorios Farmaceuticos ROVI (ROVI)
Laboratorios Farmaceuticos ROVI stock price live, this page displays BME ROVI stock exchange data. View the ROVI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Laboratorios Farmaceuticos ROVI real time stock price chart below.
What Is the Laboratorios Farmaceuticos ROVI Stock Price Today?
The Laboratorios Farmaceuticos ROVI stock price today is 56.900.
What Is the Stock Symbol for Laboratorios Farmaceuticos ROVI?
The stock symbol for Laboratorios Farmaceuticos ROVI is ""ROVI.""
What Stock Exchange Does Laboratorios Farmaceuticos ROVI Trade On?
Laboratorios Farmaceuticos ROVI is listed and trades on the Madrid stock exchange.
Is Laboratorios Farmaceuticos ROVI a Good Stock to Buy?
Determining whether Laboratorios Farmaceuticos ROVI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ROVI quote. (ISIN: ES0157261019)
What Is the Laboratorios Farmaceuticos ROVI Stock Price Today?
The Laboratorios Farmaceuticos ROVI stock price today is 56.900.
What Is the Stock Symbol for Laboratorios Farmaceuticos ROVI?
The stock symbol for Laboratorios Farmaceuticos ROVI is ""ROVI.""
What Stock Exchange Does Laboratorios Farmaceuticos ROVI Trade On?
Laboratorios Farmaceuticos ROVI is listed and trades on the Madrid stock exchange.
Is Laboratorios Farmaceuticos ROVI a Good Stock to Buy?
Determining whether Laboratorios Farmaceuticos ROVI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ROVI quote. (ISIN: ES0157261019)
56.900
+1.350(+2.43%)
Closed·
Fair Value
An estimate of a Laboratorios Farmaceuticos ROVI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.100
57.000
52 wk Range
45.520
89.500
ROVI Scorecard
Full Analysis
Significant return over the last week
ROVI is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Laboratorios Farmaceuticos ROVI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.10057.000
52 wk Range
45.52089.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ROVI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Laboratorios Farmaceuticos ROVI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
78.950
Upside
+38.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Laboratorios Farmaceuticos ROVI Company Profile
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Its products are used for cardiology, osteoarticular/women’s health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Laboratorios Farmaceuticos ROVI Earnings Call Summary for Q2/2025
- Total operating revenue down 4% YoY to €314.6M; net profit fell 10% to €39.7M despite 13% growth in specialty pharma sales
- CDMO sales declined 35%; company expects new contracts within 12 months, with commercial activities starting H2 2026
- 2025 outlook: operating revenue to decrease by mid-single digits; continued R&D investments planned for future growth
- CEO emphasizes 2025 as transition year, citing booming CDMO landscape with misalignment between supply and demand
- Stock rose 3.49% post-earnings; InvestingPro analysis shows good financial health, low volatility, and potential undervaluation
Last Updated: 24/07/2025, 09:56
Read Full TranscriptCompare ROVI to Peers and Sector
Metrics to compare | ROVI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipROVIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 20.9x | −0.5x | |
PEG Ratio | 0.00 | 1.91 | 0.00 | |
Price/Book | 0.0x | 2.3x | 2.6x | |
Price / LTM Sales | 0.0x | 2.3x | 3.2x | |
Upside (Analyst Target) | 0.0% | 11.4% | 41.6% | |
Fair Value Upside | Unlock | 25.0% | 6.0% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 78.950
(+38.75% Upside)
Earnings
Latest Release
Jul 24, 2025
EPS / Forecast
0.42 / --
Revenue / Forecast
160.00M / 161.30M
People Also Watch
FAQ
What Stock Exchange Does Laboratorios Farmaceuticos ROVI Trade On?
Laboratorios Farmaceuticos ROVI is listed and trades on the Madrid Stock Exchange stock exchange.
What Is the Stock Symbol for Laboratorios Farmaceuticos ROVI?
The stock symbol for Laboratorios Farmaceuticos ROVI is "ROVI."
What Is the Laboratorios Farmaceuticos ROVI Market Cap?
As of today, Laboratorios Farmaceuticos ROVI market cap is 2.90B.
What Is Laboratorios Farmaceuticos ROVI's Earnings Per Share (TTM)?
The Laboratorios Farmaceuticos ROVI EPS (TTM) is 2.59.
From a Technical Analysis Perspective, Is ROVI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Laboratorios Farmaceuticos ROVI Stock Split?
Laboratorios Farmaceuticos ROVI has split 0 times.
How Many Employees Does Laboratorios Farmaceuticos ROVI Have?
Laboratorios Farmaceuticos ROVI has 2188 employees.
What is the current trading status of Laboratorios Farmaceuticos ROVI (ROVI)?
As of 28 Jul 2025, Laboratorios Farmaceuticos ROVI (ROVI) is trading at a price of 56.90, with a previous close of 56.90. The stock has fluctuated within a day range of 56.10 to 57.00, while its 52-week range spans from 45.52 to 89.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.